Huawei is preparing to launch the next version of its medical-grade smartwatch. Recent entries in the Indonesian SDPPI certification database confirm that two new variants of the Huawei Watch D3 are ready for market release. The devices are identified by model numbers RIV-B10 and RIV-B11, suggesting that the company may offer multiple versions, such as variations in connectivity or hardware configurations.
This certification aligns with the company's scheduled global launch event taking place in early September. The timing suggests that the Watch D3 could share the stage with the upcoming Watch GT 7 series. Last year, the brand focused on reducing the bulkiness of its medical wearables, and the market now expects further improvements in design and health monitoring capabilities.
While the specific technical parameters remain under wraps, the certification serves as a firm indicator that the official debut is imminent. Analysts suggest the move reflects a standard product cycle for Huawei, which often aligns new wearable releases with major annual global events. Users should look for updates on potential cellular, eSIM, or color-specific variants when the official announcement occurs on September 2.
The industry continues to track how these medical wearables influence the consumer health segment. By maintaining a focus on specialized health metrics, the company keeps its competitive edge against other premium wearable manufacturers. Additional details on fitness management tools and sensor accuracy will likely arrive as part of the official presentation next month.